ABIVAX Socit Valuation
| AAVXF Stock | USD 11.05 0.00 0.00% |
At this time, the entity appears to be fairly valued. ABIVAX Socit Anonyme shows a prevailing Real Value of $11.05 per share. The current price of the entity is $11.05. Our model approximates the value of ABIVAX Socit Anonyme from evaluating the entity fundamentals such as Shares Outstanding of 22.3 M, operating margin of 4.66 %, and Shares Owned By Insiders of 4.67 % as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that ABIVAX Socit's price fluctuation is very steady at this time. Calculation of the real value of ABIVAX Socit Anonyme is based on 3 months time horizon. Increasing ABIVAX Socit's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ABIVAX pink sheet is determined by what a typical buyer is willing to pay for full or partial control of ABIVAX Socit Anonyme. Since ABIVAX Socit is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ABIVAX Pink Sheet. However, ABIVAX Socit's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.05 | Real 11.05 | Hype 11.05 | Naive 11.05 |
The real value of ABIVAX Pink Sheet, also known as its intrinsic value, is the underlying worth of ABIVAX Socit Anonyme Company, which is reflected in its stock price. It is based on ABIVAX Socit's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ABIVAX Socit's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ABIVAX Socit Anonyme helps investors to forecast how ABIVAX pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ABIVAX Socit more accurately as focusing exclusively on ABIVAX Socit's fundamentals will not take into account other important factors: ABIVAX Socit Total Value Analysis
ABIVAX Socit Anonyme is presently anticipated to have takeover price of 165.28 M with market capitalization of 165.36 M, debt of 53.45 M, and cash on hands of 26.57 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ABIVAX Socit fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
165.28 M | 165.36 M | 53.45 M | 26.57 M |
ABIVAX Socit Investor Information
About 57.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.59. ABIVAX Socit Anonyme had not issued any dividends in recent years. Based on the key indicators related to ABIVAX Socit's liquidity, profitability, solvency, and operating efficiency, ABIVAX Socit Anonyme is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.ABIVAX Socit Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ABIVAX Socit has an asset utilization ratio of 0.0335 percent. This implies that the Company is making $3.35E-4 for each dollar of assets. An increasing asset utilization means that ABIVAX Socit Anonyme is more efficient with each dollar of assets it utilizes for everyday operations.ABIVAX Socit Ownership Allocation
ABIVAX Socit holds a total of 22.3 Million outstanding shares. Over half of ABIVAX Socit's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.ABIVAX Socit Profitability Analysis
The company reported the revenue of 37 K. Net Loss for the year was (41.36 M) with loss before overhead, payroll, taxes, and interest of (45.52 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ABIVAX Socit's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ABIVAX Socit and how it compares across the competition.
About ABIVAX Socit Valuation
The pink sheet valuation mechanism determines ABIVAX Socit's current worth on a weekly basis. Our valuation model uses a comparative analysis of ABIVAX Socit. We calculate exposure to ABIVAX Socit's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ABIVAX Socit's related companies.ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.
8 Steps to conduct ABIVAX Socit's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ABIVAX Socit's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ABIVAX Socit's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ABIVAX Socit's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ABIVAX Socit's revenue streams: Identify ABIVAX Socit's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ABIVAX Socit's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ABIVAX Socit's growth potential: Evaluate ABIVAX Socit's management, business model, and growth potential.
- Determine ABIVAX Socit's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ABIVAX Socit's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ABIVAX Socit Growth Indicators
Investing in growth stocks can be very risky. If the company such as ABIVAX Socit does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 16.8 M | |
| Retained Earnings | -78.9 M |
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |